Blanchard Cheryl R — SEC Form 4 filings

SEC reporting owner CIK 1326530. 13 Form 4 filings on record with FilingPulse; latest filed 2026-04-16.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-03-05 to 2026-04-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Anika Therapeutics, Inc. (ANIK)Director732
Vigil Neuroscience, Inc. (VIGL)Director520
Xilio Therapeutics, Inc. (XLO)Director11

Form 4 filings — Blanchard Cheryl R

FiledFormIssuerReported transactionsSource
2026-04-164Xilio Therapeutics, Inc. (XLO)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2026-03-174Anika Therapeutics, Inc. (ANIK)Option exercise (M): 24,519 · Grant/award (A): 24,520 @ $0 · Tax withholding (F): 14,728 @ $14.20 · Option exercise (M): 25,131 · Tax withholding (F): 12,104 @ $14.20 · Option exercise (M): 24,519 (derivative) @ $0 · +1 moreEDGAR
2026-03-114Anika Therapeutics, Inc. (ANIK)Option exercise (M): 20,001 · Tax withholding (F): 5,871 @ $14.96 · Option exercise (M): 20,001 (derivative) @ $0EDGAR
2025-08-054Vigil Neuroscience, Inc. (VIGL)Disposition to issuer (D): 5,000 · Disposition to issuer (D): 24,761 (derivative) · Disposition to issuer (D): 24,984 (derivative) · Disposition to issuer (D): 36,690 (derivative) · Disposition to issuer (D): 18,068 (derivative) · Disposition to issuer (D): 13,928 (derivative) · +3 moreEDGAR
2025-05-234Vigil Neuroscience, Inc. (VIGL)Grant/award (A): 5,000 @ $0EDGAR
2025-03-184Anika Therapeutics, Inc. (ANIK)Option exercise (M): 25,132 @ $0 · Tax withholding (F): 12,152 @ $15.91 · Grant/award (A): 73,559 (derivative) @ $0 · Grant/award (A): 71,403 (derivative) @ $0 · Option exercise (M): 25,132 (derivative) @ $0EDGAR
2025-03-134Anika Therapeutics, Inc. (ANIK)Option exercise (M): 30,060 @ $0 · Tax withholding (F): 12,675 @ $16.79 · Option exercise (M): 30,060 (derivative) @ $0EDGAR
2025-03-114Anika Therapeutics, Inc. (ANIK)Option exercise (M): 20,002 @ $0 · Tax withholding (F): 5,871 @ $16.62 · Option exercise (M): 20,002 (derivative) @ $0EDGAR
2024-06-074Vigil Neuroscience, Inc. (VIGL)Grant/award (A): 18,068 (derivative) @ $0EDGAR
2024-05-074Vigil Neuroscience, Inc. (VIGL)Disposition to issuer (D): 5,017 (derivative) @ $9.63 · Grant/award (A): 5,017 (derivative) @ $0 · Disposition to issuer (D): 12,155 (derivative) @ $0 · Grant/award (A): 12,155 (derivative) @ $0 · Disposition to issuer (D): 6,432 (derivative) @ $7.62 · Grant/award (A): 6,432 (derivative) @ $0 · +2 moreEDGAR
2024-03-194Anika Therapeutics, Inc. (ANIK)Grant/award (A): 75,395 (derivative) @ $0 · Grant/award (A): 182,699 (derivative) @ $0EDGAR
2024-03-124Anika Therapeutics, Inc. (ANIK)Option exercise (M): 14,420 @ $0 · Tax withholding (F): 6,973 @ $25.42 · Option exercise (M): 20,001 @ $0 · Tax withholding (F): 6,473 @ $25.42 · Option exercise (M): 30,059 @ $0 · Tax withholding (F): 14,534 @ $25.79 · +3 moreEDGAR
2024-03-054Vigil Neuroscience, Inc. (VIGL)Grant/award (A): 24,761 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1326530 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →